CDK inhibitors (Institut Curie)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCDK inhibitors (Institut Curie)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsNerve DegenerationCoronary RestenosisGlomerulonephritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut Curie
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut Curie
Active IndicationsN/A
Inactive IndicationsNerve DegenerationCoronary RestenosisGlomerulonephritis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A